Clinical Trials Browser

Phase 1/2 × advexin × Clear all

NCT02842125 2020-06-02

Safety and Efficacy of Intra-Arterial and Intra-Tumoral Ad-p53 With Capecitabine (Xeloda) or Anti-PD-1 in Liver Metastases of Solid Tumors and Recurrent Head and Neck Squamous Cell Cancer

Phase 1/2 Terminated

Head and Neck Neoplasms, Neoplasm Metastasis

NCT00064103 2013-01-23

Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx

Phase 1/2 Completed

Mouth Neoplasms, Oropharyngeal Neoplasms, Tongue Neoplasms